e.g. mhealth
Search Results (1 to 10 of 646 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 184 JMIR Cancer
- 135 Journal of Medical Internet Research
- 112 JMIR Research Protocols
- 61 JMIR Formative Research
- 28 JMIR mHealth and uHealth
- 24 JMIR Dermatology
- 19 JMIR Medical Informatics
- 19 JMIR Public Health and Surveillance
- 13 JMIRx Med
- 6 JMIR Human Factors
- 6 JMIR Infodemiology
- 5 JMIR AI
- 5 JMIR Pediatrics and Parenting
- 5 JMIR Serious Games
- 4 Interactive Journal of Medical Research
- 4 Iproceedings
- 3 Journal of Participatory Medicine
- 2 JMIR Aging
- 2 JMIR Bioinformatics and Biotechnology
- 2 JMIR Medical Education
- 2 JMIR Mental Health
- 2 JMIR Perioperative Medicine
- 1 JMIR Biomedical Engineering
- 1 JMIR Cardio
- 1 JMIRx Bio
- 0 Medicine 2.0
- 0 iProceedings
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Data
- 0 JMIR Nursing
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
This constructive feedback will be incorporated into a joint Multinational Association of Supportive Care in Cancer (MASCC)/American Society of Clinical Oncology (ASCO) update of the ASCO Telehealth in Oncology Standards, which will include considerations for resource-constrained settings [7].
J Med Internet Res 2025;27:e79461
Download Citation: END BibTex RIS
Equity-Centered Optimization of Virtual Cancer Survivorship Care
We commend Scruton et al [1] for their realist evaluation of virtual follow-up (VFU) care experiences among breast and prostate cancer survivors. The study advances our understanding of contextual factors that influence VFU effectiveness and patient satisfaction. However, we offer critical reflections to strengthen equity-centered implementation of telehealth in survivorship care.
J Med Internet Res 2025;27:e73663
Download Citation: END BibTex RIS
Cancer remains a leading cause of morbidity and mortality worldwide, placing a substantial burden on health care systems. In 2022, an estimated 20 million new cancer cases and 9.7 million cancer-related deaths occurred worldwide, with approximately 53.5 million individuals living with cancer [1]. A cancer diagnosis not only presents significant challenges to health care systems but also profoundly affects patients’ daily lives.
J Med Internet Res 2025;27:e76968
Download Citation: END BibTex RIS
Cancer and its treatments cause not only physical pain but also psychological, social, and spiritual suffering to patients. However, the lack of accessible psychosocial support resources, compounded by their uneven distribution, results in many patients with cancer being unable to receive the necessary rehabilitation guidance and psychological care [1,2].
JMIR Cancer 2025;11:e64977
Download Citation: END BibTex RIS
Given known health risks of hazardous alcohol use in the general population (eg, increased risk of heart and liver disease, stroke, depression and anxiety, and reduced fertility), as well as in cancer survivors specifically (eg, increased risk of certain cancer incidence, recurrence, and even premature mortality) [2-5], helping adolescent and young adult cancer survivors reduce hazardous drinking should be a key component of survivorship care.
JMIR Cancer 2025;11:e59949
Download Citation: END BibTex RIS
Capturing Community Perspectives in a Statewide Cancer Needs Assessment: Online Focus Group Study
The Commonwealth of Kentucky has the highest all-site cancer incidence and mortality rates in the United States [1]. In 2021, a group of academic and community partners collaborated on a comprehensive, statewide cancer needs assessment (CNA) to address the state’s extensive cancer burden.
JMIR Cancer 2025;11:e63717
Download Citation: END BibTex RIS
In order to test the implementation of a federated platform with DP, a study was conducted using real-world oncology data, with the aim of analyzing the differences in the patient drug exposure of patients with non–small cell lung cancer before and after the first wave of the COVID-19 pandemic. Specifically, the analyses were based on the first line of treatment, including its duration and disease progression at 24 months.
JMIR Med Inform 2025;13:e59685
Download Citation: END BibTex RIS
As many jurisdictions use screening programs to detect and remove polyps for cancer surveillance, accurate and efficient pathology diagnosis is a key part of colon cancer screening programs [23,24]. As there are relatively few diagnostic entities for colon polyps, this area is well-suited to AI screening algorithms to assist pathologists in making a rapid diagnosis.
JMIR Form Res 2025;9:e67457
Download Citation: END BibTex RIS
Participants were eligible if they had one or more of the following health conditions: obesity; type 1 or type 2 diabetes; skin disease (eg, psoriasis, eczema, or vitiligo); HIV; chronic pain; or cancer (including in remission). These conditions represent a range of dimensions important to stigma (eg, perceived controllability, contagion, and concealability). Inclusion criteria also included self-reported perceptions and internalization of health-related stigma.
JMIR Form Res 2025;9:e69548
Download Citation: END BibTex RIS
Cancer misinformation can negatively impact health outcomes and increase mortality risk if patients forgo conventional cancer treatment for unproven alternatives [7,8]. These risks demonstrate an urgency to strengthen the growing field of online cancer misinformation scholarship.
JMIR Cancer 2025;11:e65887
Download Citation: END BibTex RIS